Hereditary Testing Market Size Worth $13.03 Billion By 2032 | CAGR: 6.80%

Hereditary Testing Market Size Worth $13.03 Billion By 2032 | CAGR: 6.80%

The global hereditary testing market size is expected to reach USD 13.03 billion by 2032, according to a new study by Polaris Market Research. The report “Hereditary Testing Market Share, Size, Trends, Industry Analysis Report, By Disease Type (Hereditary Cancer Testing and Hereditary Non-Cancer Testing); By Technology; By Region; Segment Forecast, 2024 - 2032” gives a detailed insight into the current market dynamics and provides analysis on future market growth.

The hereditary testing market has experienced significant growth due to various factors. The increasing prevalence of hereditary disorders, rising awareness about the importance of early disease detection, and advancements in genetic testing technologies have contributed to the expansion of this market. Hereditary testing is crucial in identifying genetic mutations and abnormalities, enabling early intervention, personalized treatments, and informed decision-making for patients and their families.

Moreover, there has been a notable focus on women's healthcare and reproductive genetic health in the hereditary testing market. Companies are developing and offering specialized tests for women's health, such as carrier screening and prenatal testing, to assess the risk of hereditary conditions during pregnancy and enable informed choices.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below:

However, the COVID-19 pandemic has presented challenges to the hereditary testing market. Disruptions in healthcare services, including limitations on in-person consultations and laboratory operations, have impacted the market's growth. Nevertheless, the market has shown resilience with adopting telemedicine and recognizing the importance of prenatal testing in maintaining the demand for hereditary testing services. As the understanding of genetics advances and technology continues to evolve, the hereditary testing market is expected to expand further in the coming years.

Hereditary Testing Market Report Highlights

  • The hereditary non-cancer testing segment dominated the market in 2022 and is projected to grow significantly. Major players are strategically targeting breast cancer genetic testing for revenue generation.
  • The molecular testing segment emerged as the market leader in 2022 and is expected to maintain strong growth due to increased adoption and strategic initiatives by market players.
  • Europe is projected to hold the largest revenue market share in 2022 and maintain dominance due to major genetic testing companies, widespread use of advanced therapies, and government regulations promoting hereditary testing.
  • The global key market players Twist Bioscience, MedGenome, COOPERSURGICAL, INC., Thermo Fisher Scientific, Inc., Laboratory Corporation of America Holdings, Illumina, Inc., CENTOGENE N.V., Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., SOPHiA GENETICS, Fulgent Genetics, Myriad Genetics, Inc., Natera, Inc., Invitae Corporation, and Quest Diagnostics Incorporated

Polaris Market Research has segmented the Hereditary Testing market report based on disease type, technology, and region:

Hereditary Testing, Disease Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hereditary Cancer Testing
    • Lung Cancer
    • Breast Cancer
    • Colorectal Cancer
    • Cervical Cancer
    • Ovarian Cancer
    • Prostate Cancer
    • Stomach/Gastric Cancer
    • Melanoma
    • Sarcoma
    • Uterine Cancer
    • Pancreatic Cancer
    • Others
  • Hereditary Non-Cancer Testing
    • Genetic Tests
      • Cardiac Diseases
      • Rare Diseases
      • Other Diseases
    • Newborn Genetic Screening
    • Preimplantation Genetic Diagnosis & Screening
    • Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests

Hereditary Testing, Technology Outlook (Revenue - USD Billion, 2019 - 2032)

  • Cytogenetic
  • Biochemical
  • Molecular Testing

Hereditary Testing, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa


Hereditary Testing Market Report Scope

Report Attributes


Market size value in 2024

USD 7.7 Billion

Revenue forecast in 2032

USD 13.03 Billion


6.80% from 2024 – 2032

Base year


Historical data

2019 – 2022

Forecast period

2024 – 2032

Quantitative units

Revenue in USD billion and CAGR from 2024 to 2032

Segments Covered

By Disease Type, By Technology, By Region

Regional scope

North America, Europe, Asia Pacific, Latin America; Middle East & Africa

Key Companies

AL-KO KOBER GROUP, Andreas Stihl AG & Company KG, Ariens Company, Briggs & Stratton, CHEVRON (China) Trading Co., Ltd., Deere & Company, Emak S.p.A., Excel Industries, Inc., HONDA, Husqvarna, Makita Corp, MTD Holdings Inc., Robert Bosch, Schiller Ground Care, Stanley Black & Decker, STIHL Group, Techtronic Industries, The Toro Company (US), and Yamabiko Corp.

For Specific Research Requirements

Request for Customized Report

License and Pricing

Purchase Report Sections

  • Regional analysis
  • Segmentation analysis
  • Industry outlook
  • Competitive landscape
Request for Discount Pricing